APA (7th ed.) Citation

M, M., PS, B., & C, C. (2019). Mepolizumab utility in successful aspirin desensitization in aspirin-exacerbated respiratory disease in a refractory case. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 123(3), 311. https://doi.org/10.1016/j.anai.2019.06.012

Chicago Style (17th ed.) Citation

M, Mahdavinia, Batra PS, and Codispoti C. "Mepolizumab Utility in Successful Aspirin Desensitization in Aspirin-exacerbated Respiratory Disease in a Refractory Case." Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology 123, no. 3 (2019): 311. https://doi.org/10.1016/j.anai.2019.06.012.

MLA (9th ed.) Citation

M, Mahdavinia, et al. "Mepolizumab Utility in Successful Aspirin Desensitization in Aspirin-exacerbated Respiratory Disease in a Refractory Case." Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology, vol. 123, no. 3, 2019, p. 311, https://doi.org/10.1016/j.anai.2019.06.012.